Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 and ED95 of ropivacaine concentration and volume in pediatric caudal block
ChiCTR2000034237Phase 4Not yet recruiting
- Sponsor
- Zhongshan Boai Hospital
- Start
- Jun 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine in postoperative pain (4 arms), sponsored by Zhongshan Boai Hospital. Primary endpoint: Skin incision response (hemodynamic changes). Planned start Jun 2020; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000034237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034237.